[Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
作者信息
Murakami S, Muratani H, Kikuchi T, Fujimoto S, Hayashi T, Inai S, Imaoka S
出版信息
Rinsho Byori. 1983 Jan;31(1):105-9.
PMID:6865023
Abstract
摘要
相似文献
1
2
Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.华法林治疗患者中脱γ羧基凝血酶原（PIVKA-II）和凝血因子水平。
Med Lab Sci. 1990 Apr;47(2):103-7.
3
Protein C level at birth.
Thromb Haemost. 1984 Oct 31;52(2):188-91.
4
Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants.使用口服抗凝剂的患者血浆中凝血酶原的分光光度测定。
Thromb Haemost. 1979 Dec 21;42(4):1296-305.
5
The pharmacodynamics of the oral anticoagulant drugs.口服抗凝药物的药效学
Prog Hemost Thromb. 1974;2(0):175-213.
6
[Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].[凝血过程外源性途径研究中的奎克时间及衍生时间。慢性弥散性血管内凝血状态下的异常凝血酶原（维生素K缺乏或拮抗剂诱导蛋白）]
Quad Sclavo Diagn. 1974 Dec;10(4):463-73.
7
Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.维生素K对先天性青紫型心脏病患儿凝血因子的影响。
Acta Paediatr Acad Sci Hung. 1970;11(2):135-9.
8
9
The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.口服抗凝治疗患者血浆中凝血酶原转化的抑制剂。
Thromb Haemost. 1981 Jun 30;45(3):237-41.
10
Oral anticoagulants.
Clin Haematol. 1981 Jun;10(2):459-80.
Zotero 插件